<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21065" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Viral Encephalitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Said</surname>
            <given-names>Saema</given-names>
          </name>
          <aff>RCH/UCR</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kang</surname>
            <given-names>Michael</given-names>
          </name>
          <aff>University of California Riverside School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Saema Said declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Kang declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21065.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Viral encephalitis is inflammation of the brain parenchyma caused by a virus. It is the most common type of encephalitis and often coexists with viral meningitis. Viruses invade the host outside the central nervous system and then reach the spinal cord and brain via hematogenous spread or in a retrograde manner from nerve endings. This activity describes the evaluation and management of viral encephalitis and highlights the role of the interprofessional team in improving care for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the history and physical exam findings typically seen in patients with viral encephalitis.</p></list-item><list-item><p>Review the evaluation of encephalitis.</p></list-item><list-item><p>Outline treatment options for viral encephalitis.</p></list-item><list-item><p>Summarize how the coordination of the interprofessional team can lead to rapid diagnosis of viral encephalitis and subsequently decrease associated morbidity and mortality in affected patients.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21065&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21065">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-21065.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Viral encephalitis is an inflammation of the brain parenchyma caused by a virus. It is the most common type of encephalitis and often coexists with viral meningitis. Viruses invade the host outside the central nervous system (CNS) and then reach the spinal cord and brain&#x000a0;hematogenously or in a retrograde manner from nerve endings.<xref ref-type="bibr" rid="article-21065.r1">[1]</xref><xref ref-type="bibr" rid="article-21065.r2">[2]</xref><xref ref-type="bibr" rid="article-21065.r3">[3]</xref></p>
        <p>Viral encephalitis tends to be more common in younger people compared to elderly individuals. However, the environment also plays a critical role. Many cases of viral encephalitis go undetected because of the lack of tests and mild symptoms. In addition, studies show that many patients develop high levels of antibodies to viruses but show no symptoms.</p>
      </sec>
      <sec id="article-21065.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Infectious encephalitis can be viral, bacterial, fungal, protozoal, or helminthic in etiology. The etiology of many cases of encephalitis remains unknown despite extensive workup. Viruses are the most prevalent identified cause, accounting for about 70% of confirmed cases of encephalitis. In the United States, the most common causes of viral encephalitis are herpes simplex virus (HSV), West Nile virus, and the enteroviruses. Some of the other viral etiologic agents include varicella-zoster virus, Epstein-Barr virus (EBV), cytomegalovirus (CMV), human herpesvirus type 6 and 7, measles virus, mumps virus, rubella virus, St. Louis virus, eastern equine virus, western equine virus, dengue virus, and rabies virus.<xref ref-type="bibr" rid="article-21065.r4">[4]</xref><xref ref-type="bibr" rid="article-21065.r5">[5]</xref><xref ref-type="bibr" rid="article-21065.r6">[6]</xref></p>
      </sec>
      <sec id="article-21065.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of viral encephalitis is 3.5 to 7.5 per 100,000 people, with the highest incidence in the young and elderly. The epidemiology of certain viral causes of encephalitis has changed through time. For example, vaccination has led to a decrease in the incidence of encephalitis due to mumps and measles. On the other hand, EBV and CMV encephalitis are seen more frequently now because they occur in immunocompromised individuals, such as AIDS, transplant, and chemotherapy patients. Other important epidemiologic factors include the time of the year, geography, and animal or insect exposure. For instance, arboviruses (i.e., eastern equine, western equine, St. Louis, Venezuelan equine, Zika, and West Nile)&#x000a0;cause disease during the summer months when mosquitos are active. St. Louis encephalitis is primarily seen in the Midwest and South, whereas tick-borne encephalitis occurs mainly in the North-Central and the Northeastern United States.<xref ref-type="bibr" rid="article-21065.r7">[7]</xref><xref ref-type="bibr" rid="article-21065.r8">[8]</xref><xref ref-type="bibr" rid="article-21065.r9">[9]</xref></p>
        <p>The transmission to the brain is via hematogeneous spread.</p>
        <p>In the US, herpes simplex is the most common cause of encephalitis. Individuals who work in the warm humid environments are at risk for arboviruses because of the presence of mosquitoes.</p>
      </sec>
      <sec id="article-21065.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Viruses invade the host at a site outside the CNS and replicate. Most then reach the spinal cord and brain&#x000a0;hematogenously. HSV, rabies, and herpes zoster virus&#x000a0;are important exceptions to this. They travel to the CNS&#x000a0;from nerve endings in a retrograde manner. Once in the brain, the virus and the host&#x02019;s inflammatory response disrupt neural cell function. On gross examination, there us usually cerebral edema, vascular congestion, and hemorrhage. Infiltration with leukocytes or microglial cells is also a common feature. With EEE and JE, the extent of necrosis can be significant.</p>
        <p>Following arbovirus encephalitis, calcification often is seen, especially in children.</p>
        <p>Herpes simplex tends to produce focal necrotic lesions with obvious intranuclear inclusions.</p>
      </sec>
      <sec id="article-21065.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Brain histology of individuals with viral encephalitis shows dead neurons with nuclear dissolution and hypereosinophilia within the cytoplasm on light microscopy. Because encephalitis is an inflammatory process, perivascular inflammatory cells such as microglia, macrophages, and lymphocytes are also seen. Virions within neurons can be visualized with electron microscopy, which allows for much greater magnification than light microscopy.</p>
      </sec>
      <sec id="article-21065.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>As mentioned above, the cause of many cases of encephalitis remains unknown despite extensive testing. Thus, history and physical exam play a vital role in making the diagnosis of viral encephalitis. Important elements of history include immune status, exposure to insects or animals, travel history, vaccination history, geography, and time of year. The most common sign and symptoms are fever, headache, seizures, and altered mental status. Neuropsychiatric features such as behavioral changes, hallucinations, and/or cognitive decline are often seen. Patients may also have other symptoms or exam findings that are more specific to a given&#x000a0;virus. For example, rash and skin vesicles are seen with herpes zoster encephalitis, whereas lymphadenopathy and splenomegaly are usually associated with EBV. HSV encephalitis involves the temporal and frontal lobes, so it is often characterized by psychiatric features, memory deficits, and aphasia. On the other hand, motor symptoms such as choreoathetosis and parkinsonian movements are seen with some&#x000a0;arboviruses because they predominately affect the basal ganglia.</p>
        <p>Specific features</p>
        <p>JE may lead to extrapyramidal symptoms-which mimic Parkinson disease</p>
        <p>Enterovirus 71 may cause tremor, myoclonus, ataxia, pulmonary edema, and cranial nerve palsies.</p>
        <p>Nipah virus has been shown to produce brainstem and cerebellar signs, hypertension and segmental myoclonus.</p>
        <p>Microcephaly is typical of Zika virus infection.</p>
      </sec>
      <sec id="article-21065.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Neuroimaging and lumbar puncture (LP) are essential initial diagnostic studies for evaluating patients with viral encephalitis. Computed tomography (CT) or magnetic resonance imaging (MRI) help exclude increased intracranial pressure and the risk of uncal herniation prior to performing an LP.</p>
        <p>CT may show low-density lesions in the temporal lobes when HSV is involved. These lesions usually appear 3-5 day after the infection.</p>
        <p>MRI is also the most sensitive imaging modality for showing findings consistent with HSV encephalitis, such as temporal and frontal lobe involvement. Cerebrospinal fluid (CSF) should be analyzed for opening pressure, cell counts, glucose, and protein. CSF evaluation should also include polymerase chain reaction (PCR) testing for HSV-1, HSV-2, and enteroviruses. Additional testing, such as serology for arboviruses and HIV testing, may also be done based on history and clinical presentation. Brain biopsy and body fluid specimen cultures and PCR may also be helpful in establishing the etiology in some cases.<xref ref-type="bibr" rid="article-21065.r2">[2]</xref><xref ref-type="bibr" rid="article-21065.r10">[10]</xref><xref ref-type="bibr" rid="article-21065.r11">[11]</xref></p>
        <p>The CSF will show:</p>
        <list list-type="bullet">
          <list-item>
            <p>Normal glucose</p>
          </list-item>
          <list-item>
            <p>Moderately elevated proteins</p>
          </list-item>
          <list-item>
            <p>Moderate lymphocytosis</p>
          </list-item>
        </list>
        <p>About 10% of patients will have normal CSF studies.</p>
        <p>EEG may show abnormalities in patients with seizures. JE is often associated with 3 EEG patterns that include 1) diffuse delta activity with spikes 2) diffuse continuous delta activity and 3) alpha comma activity.</p>
      </sec>
      <sec id="article-21065.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment of viral encephalitis is primarily supportive as there is no specific medical therapy for most central nervous system viral infections. A very important exception to this is HSV encephalitis. When started early, acyclovir has been shown to significantly decrease mortality and morbidity and limit the severity of long-term behavioral and cognitive impairment of HSV encephalitis. Therefore,&#x000a0;empirically,&#x000a0;it is recommended that physicians start all patients with suspected encephalitis on&#x000a0;acyclovir. The recommended dose is 10 mg/kg intravenously (IV) every 8 hours for 14 to 21 days. Although not as effective as it is with HSV, nucleoside analogs are used for other herpesviruses&#x000a0;as well. Acyclovir 10 to 15 mg/kg IV every 8 hours for 10 to 14 days, with possible adjunctive corticosteroids in immunocompetent patients, is recommended for varicella-zoster virus. The recommended treatment for CMV encephalitis is a combination of ganciclovir 5 mg/kg IV every 12 hours and foscarnet 60 mg/kg IV every 8 hours or 90 mg/kg IV every 12 hours for 21 days.</p>
        <p>Another important component of the management of patients with viral encephalitis is serial intracranial pressure (ICP) monitoring. Elevated ICP is associated with poor prognosis. Although there is limited data on their efficacy in viral encephalitis, steroids and mannitol can be given to relieve increased ICP.<xref ref-type="bibr" rid="article-21065.r12">[12]</xref><xref ref-type="bibr" rid="article-21065.r13">[13]</xref><xref ref-type="bibr" rid="article-21065.r14">[14]</xref></p>
        <p>Seizures may need to be managed with valproic acid or phenytoin. For status epilepticus, one may require benzodiazepines. For behavior alterations, one may need to use antipsychotics for a short time.</p>
      </sec>
      <sec id="article-21065.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>A broad differential diagnosis, both infectious and noninfectious, should be considered for encephalitis. These alternatives include malignancy, autoimmune or paraneoplastic diseases (e.g., anti-NMDA receptor encephalitis), brain abscess, tuberculosis or drug-induced delirium, neurosyphilis, or bacterial, fungal, protozoal, or helminthic encephalitis.</p>
      </sec>
      <sec id="article-21065.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Most patients with viral encephalitis recover without sequelae. Those who remain symptomatic have difficulties in concentration, behavioral and speech disorders, and/or memory loss. In rare cases, patients may remain in a vegetative state.</p>
        <p>Some children may develop seizures and changes in behavior following infection with WEE. Following EEE, children may develop seizures, severe mental retardation and various forms of paralysis. Zike virus infection in pregnancy may be associated with microcephaly. The most common long term complication after viral encephalitis is seizures that may occur in 10-20% of patients over several decades. These seizures often are resistant to medical therapy. Unilateral mesial temporal lobe seizures have good outcomes following neurosurgery.</p>
      </sec>
      <sec id="article-21065.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Impairment in intelligence</p>
          </list-item>
          <list-item>
            <p>Mood and behavior changes</p>
          </list-item>
          <list-item>
            <p>Residual neurological deficits</p>
          </list-item>
          <list-item>
            <p>Extrapyramidal symptoms (JE)</p>
          </list-item>
          <list-item>
            <p>Hyponatremia (esp St. Louis&#x000a0;encephalitis)</p>
          </list-item>
          <list-item>
            <p>Encephalopathy</p>
          </list-item>
          <list-item>
            <p>Mononeuropathy</p>
          </list-item>
          <list-item>
            <p>Flaccid paralysis</p>
          </list-item>
          <list-item>
            <p>SIADH (St louis encephalitis)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-21065.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Patients with viral encephalitis should be admitted to the hospital for supportive care and IV antiviral therapy. They may require intensive care for frequent neurologic exams and/or respiratory support. Early initiation of medical therapy is essential for HSV, the most common cause of viral encephalitis, so all patients with suspected encephalitis should be started empirically on acyclovir as soon as possible.</p>
      </sec>
      <sec id="article-21065.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Viral encephalitis is a serious disorder, and the morbidity and mortality depend on the type of&#x000a0;virus and the severity of the infection. Viral encephalitis may primarily involve the brain but has repercussions in many other organs; hence an interprofessional approach in management is key. It has been estimated that a single bout of viral encephalitis can cost upwards of $2 million to the healthcare system. For patients who are untreated, mortality rates can be high. Mortality after herpes encephalitis can range more than 50%, and after western equine encephalitis, children may develop marked behavior changes and seizures. The eastern equine encephalitis can also have crippling effects on children including paralysis, seizures and mental retardation. The recent Zika virus epidemic has resulted in microcephaly in newborn infants. However, mortality is low with the La Crosse and the Venezuelan equine virus. Recent data reveal that the tick-borne&#x000a0;encephalitis from the Orient is far more dangerous than the central European&#x000a0;tick-borne encephalitis. Patients who acquire the Asian tick-borne&#x000a0;encephalitis often have residual seizures for a long time.<xref ref-type="bibr" rid="article-21065.r15">[15]</xref><xref ref-type="bibr" rid="article-21065.r16">[16]</xref><xref ref-type="bibr" rid="article-21065.r17">[17]</xref></p>
        <p>The key to viral encephalitis is prevention. Surveillance of mosquitoes must be done to assess the risk of infectivity. The primary care provider, infectious disease nurse, and pharmacist should educate travelers on how to prevent mosquito bites.</p>
        <p>Travelers should wear protective garments to prevent mosquito&#x000a0;bite and sleep under a mosquito net. One should also avoid outdoor activities where the risk of tick-borne&#x000a0;infections is high. The public has to remove containers of stagnant water from the home surroundings, and insecticide spraying may help. Vaccines are available&#x000a0;against&#x000a0;the EEE, WEE and VEE. However, their effectiveness is not 100%.<xref ref-type="bibr" rid="article-21065.r18">[18]</xref><xref ref-type="bibr" rid="article-21065.r19">[19]</xref><xref ref-type="bibr" rid="article-21065.r15">[15]</xref></p>
        <p>Given the fact that complications may arise following encephalitis, establishing an interprofessional team to monitor and treat the patient is necessary. In addition to the clinical team, the other members should be therapists, rehab specialists and speech therapists</p>
      </sec>
      <sec id="article-21065.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21065&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21065">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/viral-encephalitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=21065">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21065/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21065">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-21065.s16">
        <title>References</title>
        <ref id="article-21065.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Im</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Durey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Current Status of Tick-Borne Diseases in South Korea.</article-title>
            <source>Vector Borne Zoonotic Dis</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>225</fpage>
            <page-range>225-233</page-range>
            <pub-id pub-id-type="pmid">30328790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kadambari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Harvala</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Simmonds</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pollard</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Sadarangani</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Strategies to improve detection and management of human parechovirus infection in young infants.</article-title>
            <source>Lancet Infect Dis</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>e51</fpage>
            <page-range>e51-e58</page-range>
            <pub-id pub-id-type="pmid">30322791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blom</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cuapio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sandberg</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Varnaite</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Micha&#x000eb;lsson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bj&#x000f6;rkstr&#x000f6;m</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Sandberg</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Klingstr&#x000f6;m</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lindquist</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gredmark Russ</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ljunggren</surname>
                <given-names>HG</given-names>
              </name>
            </person-group>
            <article-title>Cell-Mediated Immune Responses and Immunopathogenesis of Human Tick-Borne Encephalitis Virus-Infection.</article-title>
            <source>Front Immunol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>2174</fpage>
            <pub-id pub-id-type="pmid">30319632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Manuja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gulati</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Virmani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tripathi</surname>
                <given-names>BN</given-names>
              </name>
            </person-group>
            <article-title>Zoonotic Viral Diseases of Equines and Their Impact on Human and Animal Health.</article-title>
            <source>Open Virol J</source>
            <year>2018</year>
            <volume>12</volume>
            <fpage>80</fpage>
            <page-range>80-98</page-range>
            <pub-id pub-id-type="pmid">30288197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silva</surname>
                <given-names>ASG</given-names>
              </name>
              <name>
                <surname>Matos</surname>
                <given-names>ACD</given-names>
              </name>
              <name>
                <surname>da Cunha</surname>
                <given-names>MACR</given-names>
              </name>
              <name>
                <surname>Rehfeld</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Galinari</surname>
                <given-names>GCF</given-names>
              </name>
              <name>
                <surname>Marcelino</surname>
                <given-names>SAC</given-names>
              </name>
              <name>
                <surname>Saraiva</surname>
                <given-names>LHG</given-names>
              </name>
              <name>
                <surname>Martins</surname>
                <given-names>NRDS</given-names>
              </name>
              <name>
                <surname>Maranh&#x000e3;o</surname>
                <given-names>RPA</given-names>
              </name>
              <name>
                <surname>Lobato</surname>
                <given-names>ZIP</given-names>
              </name>
              <name>
                <surname>Pierezan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Guedes</surname>
                <given-names>MIMC</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>West Nile virus associated with equid encephalitis in Brazil, 2018.</article-title>
            <source>Transbound Emerg Dis</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>445</fpage>
            <page-range>445-453</page-range>
            <pub-id pub-id-type="pmid">30318735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soung</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Viral Encephalitis and Neurologic Diseases: Focus on Astrocytes.</article-title>
            <source>Trends Mol Med</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>11</issue>
            <fpage>950</fpage>
            <page-range>950-962</page-range>
            <pub-id pub-id-type="pmid">30314877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baldwin</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Herpesvirus Infections of the Nervous System.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>5, Neuroinfectious Disease</issue>
            <fpage>1349</fpage>
            <page-range>1349-1369</page-range>
            <pub-id pub-id-type="pmid">30273243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phipps</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>McElhinney</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>West Nile virus season in Europe.</article-title>
            <source>Vet Rec</source>
            <year>2018</year>
            <month>Aug</month>
            <day>18</day>
            <volume>183</volume>
            <issue>7</issue>
            <fpage>224</fpage>
            <pub-id pub-id-type="pmid">30120184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ben Abid</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Abukhattab</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ghazouani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Khalil</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Gohar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al Soub</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Al Maslamani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Al Khal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al Masalamani</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Al Dhahry</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hashim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Howadi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Butt</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and clinical outcomes of viral central nervous system infections.</article-title>
            <source>Int J Infect Dis</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>73</volume>
            <fpage>85</fpage>
            <page-range>85-90</page-range>
            <pub-id pub-id-type="pmid">29913285</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leahy</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Mathur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Majeed</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The clinical approach to managing herpes simplex virus encephalitis.</article-title>
            <source>Br J Hosp Med (Lond)</source>
            <year>2018</year>
            <month>Oct</month>
            <day>02</day>
            <volume>79</volume>
            <issue>10</issue>
            <fpage>556</fpage>
            <page-range>556-559</page-range>
            <pub-id pub-id-type="pmid">30290743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jayaraman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rangasami</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chandrasekharan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Magnetic Resonance Imaging Findings in Viral Encephalitis: A Pictorial Essay.</article-title>
            <source>J Neurosci Rural Pract</source>
            <year>2018</year>
            <season>Oct-Dec</season>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>556</fpage>
            <page-range>556-560</page-range>
            <pub-id pub-id-type="pmid">30271050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reid</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thakur</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>Nervous System Infections and the Global Traveler.</article-title>
            <source>Semin Neurol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-262</page-range>
            <pub-id pub-id-type="pmid">29791951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaieski</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Emergency Neurologic Life Support: Meningitis and Encephalitis.</article-title>
            <source>Neurocrit Care</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>Suppl 1</issue>
            <fpage>124</fpage>
            <page-range>124-133</page-range>
            <pub-id pub-id-type="pmid">28916998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taba</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schmutzhard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Forsberg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lutsar</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lj&#x000f8;stad</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Mygland</surname>
                <given-names>&#x000c5;</given-names>
              </name>
              <name>
                <surname>Levchenko</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Strle</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis.</article-title>
            <source>Eur J Neurol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>10</issue>
            <fpage>1214</fpage>
            <page-range>1214-e61</page-range>
            <pub-id pub-id-type="pmid">28762591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beaman</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Community-acquired acute meningitis and encephalitis: a narrative review.</article-title>
            <source>Med J Aust</source>
            <year>2018</year>
            <month>Nov</month>
            <day>19</day>
            <volume>209</volume>
            <issue>10</issue>
            <fpage>449</fpage>
            <page-range>449-454</page-range>
            <pub-id pub-id-type="pmid">30309300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lyons</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Viral Meningitis and Encephalitis.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>5, Neuroinfectious Disease</issue>
            <fpage>1284</fpage>
            <page-range>1284-1297</page-range>
            <pub-id pub-id-type="pmid">30273240</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Status epilepticus associated with acute encephalitis: long-term follow-up of functional and cognitive outcomes in 72 patients.</article-title>
            <source>Eur J Neurol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>25</volume>
            <issue>10</issue>
            <fpage>1228</fpage>
            <page-range>1228-1234</page-range>
            <pub-id pub-id-type="pmid">29751371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gyawali</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Taylor-Robinson</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Confronting the Emerging Threat to Public Health in Northern Australia of Neglected Indigenous Arboviruses.</article-title>
            <source>Trop Med Infect Dis</source>
            <year>2017</year>
            <month>Oct</month>
            <day>17</day>
            <volume>2</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">30270912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21065.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charlier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Beaudoin</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Couderc</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lortholary</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Lecuit</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Arboviruses and pregnancy: maternal, fetal, and neonatal effects.</article-title>
            <source>Lancet Child Adolesc Health</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>134</fpage>
            <page-range>134-146</page-range>
            <pub-id pub-id-type="pmid">30169203</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
